BiomX Inc. (PHGE), a clinical-stage biopharmaceutical company, Thursday announced a one-for-ten reverse stock split effective August 26.
The stock split, which is already approved by the company's shareholders, will reduce its shares to about 17.9 million from 178.96 million.
BiomX shares were down more than 4 percent in pre-market to $0.1750.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.